AMGN vs QGEN
Amgen Inc. and Qiagen N.v., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | AMGN | QGEN |
|---|---|---|
| Revenue | $36.8B | $2.1B |
| Net income | $7.7B | $424.9M |
| Gross margin | 67.2% | 62.2% |
| Net margin | 21.0% | 20.3% |
| Return on equity | 106.1% | 11.6% |
| Diluted EPS | $14.23 | $1.94 |
| Dividend / share | $9.66 | $0.25 |
| Payout ratio | 66.5% | 12.8% |
| Free cash flow | $8.1B | $453.3M |
| Equity | $8.7B | $3.8B |
| Net debt / equity | 5.25× | 0.22× |
| Current ratio | 1.14× | 3.90× |
| Revenue CAGR 5y | 7.6% | 2.2% |
| Profit CAGR 5y | 1.2% | 3.4% |
AMGN bills 17.6× the revenue of QGEN, and keeps more of each dollar of revenue as profit (21.0% against 20.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | AMGN | QGEN |
|---|---|---|
| FY2025 | $36.8B | $2.1B |
| FY2024 | $33.4B | $2.0B |
| FY2023 | $28.2B | $2.0B |
| FY2022 | $26.3B | $2.1B |
| FY2021 | $26.0B | $2.3B |
| FY2020 | $25.4B | $1.9B |
| FY2019 | $23.4B | $1.5B |
| FY2018 | $23.7B | $1.5B |
| FY2017 | $22.8B | $1.4B |
| FY2016 | $23.0B | $1.3B |
Net income by year
Bottom line
| Fiscal year | AMGN | QGEN |
|---|---|---|
| FY2025 | $7.7B | $424.9M |
| FY2024 | $4.1B | $83.6M |
| FY2023 | $6.7B | $341.3M |
| FY2022 | $6.6B | $423.2M |
| FY2021 | $5.9B | $512.6M |
| FY2020 | $7.3B | $359.2M |
| FY2019 | $7.8B | $-41.5M |
| FY2018 | $8.4B | $190.4M |
| FY2017 | $2.0B | $40.4M |
| FY2016 | $7.7B | $80.4M |
Advertisement
AdSense · Rectangle 336×280
More in this industry